✦ LIBER ✦

110 SERUM LEVELS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR AND EPIDERMAL GROWTH FACTOR RECEPTOR IN PATIENTS WITH PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA

✍ Scribed by G. Milanese; L. Gasparri; S. Nicolai; M. Canonico; V. Lacetera; M. Dellabella; A.B. Galosi; F. Fazioli; F. Blasi; G. Muzzonigro

Book ID: 119617442
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 320 KB
Volume: 6
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(07)60109-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased Urokinase-Type Plasminogen Act

Increased Urokinase-Type Plasminogen Activator Receptor and Epidermal Growth Factor Receptor in Serum of Patients With Prostate Cancer

✍ Milanese, Giulio; Dellabella, Marco; Fazioli, Francesca; Pierpaoli, Elisa; Polit 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 246 KB

Elevation of serum levels of urokinase-t

Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer

✍ Miyake, Hideaki; Hara, Isao; Yamanaka, Kazuki; Gohji, Kazuo; Arakawa, Soichi; Ka 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

BACKGROUND. Several investigators have revealed that urokinase-type plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in serum as well as in tumor tissues in patients with various types of cancer. In this study, we examined whether the serum levels of uPA and uPAR could be used a

Physiological and pathological changes o

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

✍ Hyun Cheol Chung; Sun Young Rha; Joon Oh Park; Nae Choon Yoo; Joo Hang Kim; Jae 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 670 KB

CAN THE INTRAPROSTATIC CONCENTRATION OF

CAN THE INTRAPROSTATIC CONCENTRATION OF EPIDERMAL GROWTH FACTOR INFLUENCE THE VARIANCE OF SERUM PROSTATE SPECIFIC ANTIGEN LEVELS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA?

✍ Di SILVERIO, F.; SCIARRA, A.; MONTI, S.; CASALE, P.; SECCARECCIA, F. 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 613 KB

Comparative analysis of epidermal growth

Comparative analysis of epidermal growth factor receptor mRNA levels in normal, benign hyperplastic and carcinomatous prostate

✍ Vijay L Kumar; Pradip K Majumder; Sumeet Gujral; Vijay Kumar 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Association of PSA, testosterone, folist

Association of PSA, testosterone, folistatin, activin and cortisol serum levels in patients with benign prostate hyperplasia and prostate cancer

✍ T. Deix; B. Planz; S. Madersbacher; H.P. Caspers; H. Oltean; G. Schatzl; A. Gsur 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 206 KB